AWB

Vaccines

National Biotech Week in Saskatchewan: Serious fun.

Saskatchewan takes National Biotech Week seriously. After all, biotechnology makes our lives better and easier, from health technologies, to hardier crops, eco-friendly products and cleaning up the environment. So we host events with names like the Walking Dead Dance, the Amazing Biotech Race and …

Read More


RNA interference: Big potential for agriculture

by Jackie Robin, AWB In a California lab in the 1980s, U.S. researcher Richard Jorgensen tried to develop an intense-purple petunia by adding an extra gene. He got a white flower instead. It took more than a decade for scientists to fully understand what had happened, but now they know: Jorgen …

Read More


VIDO-InterVac: Leading Vaccine Discovery

Risk group 3 (RG3) infectious diseases have the potential to cause serious health and economic consequences.  For example, Porcine Epidemic Diarrhea Virus and Middle East Respiratory Syndrome Coronavirus have caused recent concerns in North America.  To combat the threat of these types …

Read More


Vaccines: Challenges & Opportunities

by Andrew Potter Infectious diseases of humans and animals have historically been the leading cause of death worldwide, a situation that has not changed to this day. These diseases are now in the public eye more than ever; indeed, it is difficult to go for more than a week without the media discu …

Read More


VIDO-InterVac: Keeping Canada at forefront of discovery science

Vaccine and Infectious Disease Organization’s International Vaccine Centre achieves certification New vaccine research and development against existing and emerging diseases can now proceed thanks to final certification of the Vaccine and Infectious Disease Organization’s Internationa …

Read More


PREVENT announces a license to develop a seasonal influenza vaccine

The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercialization and Research (CECR) headquartered at the University of Saskatchewan, signed an exclusive license with Folia Biotech in Quebec for the rights to use propriety PAL adjuvant technology in the dev …

Read More


InterVac: New opportunities in infectious disease research

During the past decade the world has been challenged by a number of emerging and re-emerging infectious diseases affecting both humans and animals. Examples include SARS, tuberculosis, avian and swine influenza, West Nile virus, and neurodegenerative prion diseases including bovine spongiform enceph …

Read More


U of S Professor Emeritus and former VIDO Director honored

by Kathryn Warden, U of S Research Communications University of Saskatchewan Professor Emeritus Lorne Babiuk has been awarded the prestigious Canada Gairdner Wightman Award in recognition of his accomplishments over three decades that include leading the U of S Vaccine and Infectious Disease …

Read More